Joints First
Natural health product licensed in Canada
- Other names
- Health First Joints First Capsules
- Licence holder
- Health First Network
- NPN or DIN-HM
- 80090647
- Status
- Active licence
- Licence date
- 17 February 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose Source : Exosquelette de crabe | 150 milligramme | Not calculated |
| Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose Source : Chlorhydrate de glucosamine | 150 milligramme | Not calculated |
| Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose Source : Exosquelette de crevette | 150 milligramme | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 20 milligramme | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 180,000 FCC PU | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Exosquelette de crevette | 150 milligramme | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Exosquelette de crabe | 150 milligramme | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Sulfate de glucosamine chlorure de potassium | 150 milligramme | Not calculated |
| Boswellia serrata Source : Stem bark oleogum resin Potency : 65 % Boswellic acids | 60 milligramme | Not calculated |
| Collagène de type II hydrolysé Source : Hydrolyzed Collagen Type II | 30 milligramme | Not calculated |
| Salix alba Source : Écorce (tige) | 25 milligramme | Not calculated |
Non-medicinal ingredients
Eau purifiée, Dioxyde de silicium colloïdal, Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in maintaining healthy cartilage. Helps to relieve joint pain associated with osteoarthritis. Helps to relieve pain associated with osteoarthritis of the knee.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80090647
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.